Elite Pharmaceuticals, Inc. (ELTP) SEC filings
ELTP SEC filings moved a median of -0.81% by the close. ELTP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ELTP overview →
52 measured ELTP SEC filing events.
Where these ELTP SEC filings landedvs 51 measured ELTP SEC filing reactions
| Middle 50% of ELTP SEC filing reactions | -8.00% to +3.87% |
|---|---|
| Median reaction (to close) | -0.81% |
| Measured reactions | 51 |
Point-in-time · zero look-ahead
Half of the 51 ELTP SEC filing events with a measured close landed between -8.00% and +3.87%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ELITE PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -3.50% | +3.33% | |
| Form 8-K ELITE PHARMACEUTICALS For: Aug 13 | SEC filing · Form 8-K | -3.50% | +3.33% | |
| Form 8-K/A ELITE PHARMACEUTICALS For: Aug 10 | SEC filing · Form 8-K | +0.85% | -0.55% | |
| Form 8-K ELITE PHARMACEUTICALS For: Aug 04 | SEC filing · Form 8-K | -1.18% | -3.47% | |
| Form 10-K ELITE PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-K | +1.22% | -7.62% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 29 | SEC filing · Form 8-K | +1.22% | -7.62% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 23 | SEC filing · Form 8-K | +1.53% | -0.30% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 15 | SEC filing · Form 8-K | +1.93% | +6.52% | |
| Form 8-K ELITE PHARMACEUTICALS For: May 29 | SEC filing · Form 8-K | +1.45% | +3.78% | |
| Form 8-K ELITE PHARMACEUTICALS For: Apr 02 | SEC filing · Form 8-K | +0.00% | +0.50% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-Q | -9.15% | -16.91% | |
| Form 8-K ELITE PHARMACEUTICALS For: Feb 17 | SEC filing · Form 8-K | -9.15% | -16.91% | |
| Form 8-K ELITE PHARMACEUTICALS For: Feb 11 | SEC filing · Form 8-K | +0.00% | -2.75% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -1.70% | -8.38% | |
| Form 8-K ELITE PHARMACEUTICALS For: Nov 14 | SEC filing · Form 8-K | -1.70% | -8.38% | |
| Form 8-K ELITE PHARMACEUTICALS For: Nov 12 | SEC filing · Form 8-K | +1.23% | +3.96% | |
| Form 8-K/A ELITE PHARMACEUTICALS For: Nov 10 | SEC filing · Form 8-K | -1.92% | — | |
| Form 8-K ELITE PHARMACEUTICALS For: Nov 10 | SEC filing · Form 8-K | -1.32% | -0.81% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -1.57% | -11.04% | |
| Form 8-K ELITE PHARMACEUTICALS For: Aug 14 | SEC filing · Form 8-K | -1.57% | -11.04% | |
| Form 8-K ELITE PHARMACEUTICALS For: Aug 08 | SEC filing · Form 8-K | +0.86% | -1.74% | |
| Form 10-K ELITE PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-K | -3.32% | -13.97% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 30 | SEC filing · Form 8-K | -3.32% | -13.97% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 23 | SEC filing · Form 8-K | +6.36% | +1.08% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 16 | SEC filing · Form 8-K | +4.07% | +4.22% | |
| Form 8-K ELITE PHARMACEUTICALS For: Apr 30 | SEC filing · Form 8-K | +2.36% | +1.19% | |
| Form 8-K ELITE PHARMACEUTICALS For: Feb 28 | SEC filing · Form 8-K | -2.04% | -1.53% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-Q | +1.09% | +17.75% | |
| Form 8-K ELITE PHARMACEUTICALS For: Feb 13 | SEC filing · Form 8-K | +1.09% | +17.75% | |
| Form 8-K ELITE PHARMACEUTICALS For: Dec 26 | SEC filing · Form 8-K | -0.54% | +0.41% | |
| Form 8-K ELITE PHARMACEUTICALS For: Dec 02 | SEC filing · Form 8-K | -0.60% | -2.74% | |
| Form 8-K ELITE PHARMACEUTICALS For: Nov 18 | SEC filing · Form 8-K | -2.94% | -3.56% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -1.89% | +12.32% | |
| Form 8-K ELITE PHARMACEUTICALS For: Nov 14 | SEC filing · Form 8-K | -1.89% | +12.32% | |
| Form 8-K ELITE PHARMACEUTICALS For: Oct 10 | SEC filing · Form 8-K | -1.21% | +4.75% | |
| Form 8-K ELITE PHARMACEUTICALS For: Oct 07 | SEC filing · Form 8-K | +1.54% | +1.18% | |
| Form 8-K ELITE PHARMACEUTICALS For: Aug 27 | SEC filing · Form 8-K | +2.70% | +9.04% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -1.31% | -3.97% | |
| Form 8-K ELITE PHARMACEUTICALS For: Aug 14 | SEC filing · Form 8-K | -1.31% | -3.97% | |
| Form 10-K ELITE PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-K | -0.02% | -10.74% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jul 01 | SEC filing · Form 8-K | -0.02% | -10.74% | |
| Form S-8 ELITE PHARMACEUTICALS | SEC filing · Form S-8 | -0.02% | -10.74% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 17 | SEC filing · Form 8-K | +6.10% | +7.99% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 01 | SEC filing · Form 8-K | +0.00% | +4.69% | |
| Form 8-K ELITE PHARMACEUTICALS For: May 20 | SEC filing · Form 8-K | -1.12% | +0.74% | |
| Form S-8 ELITE PHARMACEUTICALS | SEC filing · Form S-8 | -0.39% | -1.67% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-Q | -3.56% | -11.06% | |
| Form 8-K ELITE PHARMACEUTICALS For: Feb 14 | SEC filing · Form 8-K | -3.56% | -11.06% | |
| Form 8-K ELITE PHARMACEUTICALS For: Dec 26 | SEC filing · Form 8-K | -3.43% | +0.54% | |
| Form 8-K ELITE PHARMACEUTICALS For: Dec 12 | SEC filing · Form 8-K | +0.00% | -0.86% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +14.02% | +11.11% | |
| Form 8-K ELITE PHARMACEUTICALS For: Nov 14 | SEC filing · Form 8-K | +14.02% | +11.11% |
Keep exploring
More ELTP: earnings → · analyst actions → · ELTP overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Homology Medicines, Inc. (FIXX) | 80 | -0.34% | 33% |
| Orchard Therapeutics plc - American Depositary Shares (ORTX) | 80 | +0.06% | 66% |
| Genetic Technologies Ltd - American Depositary Shares (GENE) | 79 | -0.05% | 33% |
| MOTIF BIO PLC ADRS (MTFB) | 79 | 0.00% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.